160 related articles for article (PubMed ID: 35351089)
41. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
Zhou H; Lei X; Yan Y; Lydic T; Li J; Weintraub NL; Su H; Chen W
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31185001
[TBL] [Abstract][Full Text] [Related]
42. Congenital generalized lipodystrophy in a 4 year old Chinese girl.
Dong G; Liang L; Zou C
Indian Pediatr; 2005 Oct; 42(10):1036-8. PubMed ID: 16269843
[TBL] [Abstract][Full Text] [Related]
43. [Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases].
Cardona-Hernández R; Suárez-Ortega L; Torres M
An Pediatr (Barc); 2011 Feb; 74(2):126-30. PubMed ID: 21168376
[TBL] [Abstract][Full Text] [Related]
44. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation.
Friguls B; Coroleu W; del Alcazar R; Hilbert P; Van Maldergem L; Pintos-Morell G
Eur J Med Genet; 2009; 52(1):14-6. PubMed ID: 19041432
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.
Simha V; Garg A
J Clin Endocrinol Metab; 2003 Nov; 88(11):5433-7. PubMed ID: 14602785
[TBL] [Abstract][Full Text] [Related]
46. [Congenital generalized lipodystrophy: a case report with neurological involvement].
Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Hubert P; Douira W; Ben Dridi MF
Arch Pediatr; 2009 Jan; 16(1):27-31. PubMed ID: 19026526
[TBL] [Abstract][Full Text] [Related]
47. Towards a mechanistic understanding of lipodystrophy and seipin functions.
Wee K; Yang W; Sugii S; Han W
Biosci Rep; 2014 Oct; 34(5):. PubMed ID: 25195639
[TBL] [Abstract][Full Text] [Related]
48. Generalized lipoatrophy syndromes.
Sorkina E; Chichkova V
Presse Med; 2021 Nov; 50(3):104075. PubMed ID: 34562560
[TBL] [Abstract][Full Text] [Related]
49. Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
Patni N; Xing C; Agarwal AK; Garg A
Am J Med Genet A; 2017 Sep; 173(9):2517-2521. PubMed ID: 28686329
[TBL] [Abstract][Full Text] [Related]
50. Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease.
Mcilroy GD; Suchacki K; Roelofs AJ; Yang W; Fu Y; Bai B; Wallace RJ; De Bari C; Cawthorn WP; Han W; Delibegović M; Rochford JJ
Mol Metab; 2018 Apr; 10():55-65. PubMed ID: 29459250
[TBL] [Abstract][Full Text] [Related]
51. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
[TBL] [Abstract][Full Text] [Related]
52. Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO.
da Cunha Olegario NB; da Cunha Neto JS; Barbosa PCS; Pinheiro PR; Landim PLA; Montenegro APDR; Fernandes VO; de Albuquerque VHC; Duarte JBF; da Cruz Paiva Lima GE; Junior RMM
Sci Rep; 2023 Feb; 13(1):2176. PubMed ID: 36750605
[TBL] [Abstract][Full Text] [Related]
53. A New Compound Heterozygous Mutation Of
Qin YY; Zhang X; Xiang LQ; Shan QW; Li SD; Yan J; Lin FQ
Diabetes Metab Syndr Obes; 2019; 12():2583-2587. PubMed ID: 31824185
[TBL] [Abstract][Full Text] [Related]
54. Berardinelli Seip Syndrome: A rare case report.
Ashraf S; Masood S; Naz F; Rashid J
J Pak Med Assoc; 2022 May; 72(5):969-971. PubMed ID: 35713067
[TBL] [Abstract][Full Text] [Related]
55. A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
Fukaishi T; Minami I; Masuda S; Miyachi Y; Tsujimoto K; Izumiyama H; Hashimoto K; Yoshida M; Takahashi S; Kashimada K; Morio T; Kosaki K; Maezawa Y; Yokote K; Yoshimoto T; Yamada T
Endocr J; 2020 Feb; 67(2):211-218. PubMed ID: 31708526
[TBL] [Abstract][Full Text] [Related]
56. Medical management of a child with congenital generalized lipodystrophy accompanied with progressive myoclonic epilepsy: A case report.
Zhang Y; Chen X; Luo F; Jiang L; Xu J; Chen S
Medicine (Baltimore); 2019 Nov; 98(48):e18121. PubMed ID: 31770241
[TBL] [Abstract][Full Text] [Related]
57. [Congenital generalized lipodystrophy in a patient with Dandy Walker anomaly].
Luna CI; Fernández Cordero M; Escruela R; Sierra V; Córdoba A; Goñi IM; Berridi R
Arch Argent Pediatr; 2014 Oct; 112(5):e196-9. PubMed ID: 25192534
[TBL] [Abstract][Full Text] [Related]
58. Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.
Vatier C; Vantyghem MC; Storey C; Jéru I; Christin-Maitre S; Fève B; Lascols O; Beltrand J; Carel JC; Vigouroux C; Bismuth E
Curr Med Res Opin; 2019 Mar; 35(3):543-552. PubMed ID: 30296183
[TBL] [Abstract][Full Text] [Related]
59. Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X
Sorkina E; Makarova P; Bolotskaya L; Ulyanova I; Chernova T; Tiulpakov A
Clin Diabetes Endocrinol; 2020; 6():7. PubMed ID: 32467771
[TBL] [Abstract][Full Text] [Related]
60. The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation.
Chen W; Yechoor VK; Chang BH; Li MV; March KL; Chan L
Endocrinology; 2009 Oct; 150(10):4552-61. PubMed ID: 19574402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
